Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bicycle Therapeutics (BCYC) Non Operating Income (2018 - 2025)

Bicycle Therapeutics' Non Operating Income history spans 8 years, with the latest figure at $5.8 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 60.49% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $28.3 million, down 21.67%, while the annual FY2025 figure was $28.3 million, 21.67% down from the prior year.
  • Non Operating Income reached $5.8 million in Q4 2025 per BCYC's latest filing, down from $6.7 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $14.7 million in Q4 2024 to a low of -$799000.0 in Q3 2021.
  • Average Non Operating Income over 5 years is $3.7 million, with a median of $2.6 million recorded in 2023.
  • Peak YoY movement for Non Operating Income: crashed 1209.72% in 2021, then skyrocketed 77322.22% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$761000.0 in 2021, then skyrocketed by 338.24% to $1.8 million in 2022, then skyrocketed by 200.94% to $5.5 million in 2023, then soared by 169.92% to $14.7 million in 2024, then plummeted by 60.49% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Non Operating Income are $5.8 million (Q4 2025), $6.7 million (Q3 2025), and $7.4 million (Q2 2025).